Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)
Scope of the Report
The report titled “Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)”, provides an in depth analysis of the global immuno-oncology market by value and by region. The report provides a detailed analysis of the immuno-oncology assays market by value, by region, by application, etc. The report also provides a regional analysis of the immuno-oncology market, including the following regions: North America and Rest of World. Also detailed regional analysis of immuno-oncology assays market, including regions: North America, Europe and APAC.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global immuno-oncology market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global immuno-oncology market is dominated with few major market players operating worldwide. Further, key players of the immuno-oncology market with focus on assays are Merck and Co., Pfizer Inc., Amgen and F. Hoffmann-La Roche are also profiled with their financial information and respective business strategies.
Country Coverage
Immuno-oncology, also called as cancer immunotherapy work with the help of the organs of the immune system detecting the cancer cells as foreign bodies and thereby helping to fight against cancer. Immunotherapies help to cure lung cancer, prostate cancer, breast cancer, colorectal cancer, melanoma, head and neck cancer and various other types. There are certain benefits and risks involved in treating the cancer with the help of immunotherapies, so care must be taken while using immunotherapy along with the conventional therapies in the treatment.
Immuno-Oncology deals with the immune system that works by recognizing the cancer cells while immuno-oncology assays are used to study about a drug reaction in a tumor microenvironment.
Immuno-Oncology assays are the next generation sequencing application which helps in maintaining the cell health and the cell forms by ensuring the continuous analysis. The cell based immuno-oncology assays can be segmented into T Cell Assays, Natural Killer Cell Assays, Tumor Killing Assays and Tumor Cell Assays.
The global immuno-oncology market has increased at a significant growth during the year 2018 and projections are made that the market would rise in the next four years at a significant CAGR i.e. 2019-2023 tremendously. The immuno-oncology market is expected to increase due to the rising number of cancer cases, unhealthy changes in dietary patterns, higher investments in the research and development, growing approvals of medicines for the treatment of various types of cancer, etc. Yet the market faces some challenges such as high cost of immunotherapies, side-effects post immunotherapy and the declining composite success rate of oncology clinical trials, etc.
The report titled “Global Immuno-Oncology Market with Focus on Assays: Size, Trends and Forecasts (2019-2023)”, provides an in depth analysis of the global immuno-oncology market by value and by region. The report provides a detailed analysis of the immuno-oncology assays market by value, by region, by application, etc. The report also provides a regional analysis of the immuno-oncology market, including the following regions: North America and Rest of World. Also detailed regional analysis of immuno-oncology assays market, including regions: North America, Europe and APAC.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global immuno-oncology market has also been forecasted for the period 2019-2023, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The global immuno-oncology market is dominated with few major market players operating worldwide. Further, key players of the immuno-oncology market with focus on assays are Merck and Co., Pfizer Inc., Amgen and F. Hoffmann-La Roche are also profiled with their financial information and respective business strategies.
Country Coverage
- North America
- Europe
- APAC
- Merck and Co.
- Pfizer Inc.
- Amgen
- F. Hoffmann-La Roche
Immuno-oncology, also called as cancer immunotherapy work with the help of the organs of the immune system detecting the cancer cells as foreign bodies and thereby helping to fight against cancer. Immunotherapies help to cure lung cancer, prostate cancer, breast cancer, colorectal cancer, melanoma, head and neck cancer and various other types. There are certain benefits and risks involved in treating the cancer with the help of immunotherapies, so care must be taken while using immunotherapy along with the conventional therapies in the treatment.
Immuno-Oncology deals with the immune system that works by recognizing the cancer cells while immuno-oncology assays are used to study about a drug reaction in a tumor microenvironment.
Immuno-Oncology assays are the next generation sequencing application which helps in maintaining the cell health and the cell forms by ensuring the continuous analysis. The cell based immuno-oncology assays can be segmented into T Cell Assays, Natural Killer Cell Assays, Tumor Killing Assays and Tumor Cell Assays.
The global immuno-oncology market has increased at a significant growth during the year 2018 and projections are made that the market would rise in the next four years at a significant CAGR i.e. 2019-2023 tremendously. The immuno-oncology market is expected to increase due to the rising number of cancer cases, unhealthy changes in dietary patterns, higher investments in the research and development, growing approvals of medicines for the treatment of various types of cancer, etc. Yet the market faces some challenges such as high cost of immunotherapies, side-effects post immunotherapy and the declining composite success rate of oncology clinical trials, etc.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Immuno-Oncology: An Overview
2.1.1 Introduction
2.1.2 Cancer-Targeting Immunotherapies
2.2 Immuno-Oncology Segmentation
2.2.1 Immuno-Oncology Segmentation by Application
2.3 Working of Immuno-Oncology
2.4 Benefits and Risks of Immuno-Oncology
2.4.1 Benefits of Immuno-Oncology
2.4.2 Risks of Immuno-Oncology
2.5 Immuno-Oncology Assays: An Overview
2.5.1 Introduction
2.5.2 Immuno-Oncology Assays Types
2.6 Immuno-Oncology Assays Segmentation
2.6.1 Immuno-Oncology Assays Segmentation by Technology
3. GLOBAL MARKET ANALYSIS
3.1 Global Immuno-Oncology Market Analysis
3.1.1 Global Immuno-Oncology Market by Value
3.1.2 Global Immuno-Oncology Market by Region (North America and ROW)
3.2 Global Immuno-Oncology Assays Market Analysis
3.2.1 Global Immuno-Oncology Assays Market by Value
3.2.2 Global Immuno-Oncology Assays Market by Region (North America, Europe, Asia-Pacific and Rest of World)
3.2.3 Global Immuno-Oncology Assays Market by Application (Clinical Diagnostic and Research)
4. REGIONAL MARKET ANALYSIS
4.1 North America Immuno-Oncology Market Analysis
4.1.1 North America Immuno-Oncology Market by Value
4.2 ROW Immuno-Oncology Market Analysis
4.2.1 ROW Immuno-Oncology Market by Value
4.3 North America Immuno-Oncology Assays Market Analysis
4.3.1 North America Immuno-Oncology Assays Market by Value
4.4 Europe Immuno-Oncology Assays Market Analysis
4.4.1 Europe Immuno-Oncology Assays Market by Value
4.5 APAC Immuno-Oncology Assays Market Analysis
4.5.1 APAC Immuno-Oncology Assays Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Increase in Oncology Spending
5.1.2 Approval of New Active Substance (NAS) in Oncology
5.1.3 Rising Cancer Cases
5.1.4 Unhealthy Changes in Dietary Patterns
5.1.5 Excessive Use of Tobacco
5.1.6 Rise in Alcohol Consumption
5.2 Challenges
5.2.1 Lower Composite Success Rate of Oncology Clinical Trials
5.2.2 Side-Effects after Immunotherapy
5.2.3 High Cost Involved
5.3 Market Trends
5.3.1 Evolution of Biosimilars in Oncology
5.3.2 Accelerating Immuno-Oncology Research
5.3.3 Purchasing and Reimbursement Actions
6. COMPETITIVE LANDSCAPE
6.1 Global Immuno-Oncology Market: A Financial Comparison
6.2 Global Immuno-Oncology Market Players by Research and Development
7. COMPANY PROFILES
7.1 Merck and Co.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Pfizer Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Amgen
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 F. Hoffmann-La Roche
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
2. INTRODUCTION
2.1 Immuno-Oncology: An Overview
2.1.1 Introduction
2.1.2 Cancer-Targeting Immunotherapies
2.2 Immuno-Oncology Segmentation
2.2.1 Immuno-Oncology Segmentation by Application
2.3 Working of Immuno-Oncology
2.4 Benefits and Risks of Immuno-Oncology
2.4.1 Benefits of Immuno-Oncology
2.4.2 Risks of Immuno-Oncology
2.5 Immuno-Oncology Assays: An Overview
2.5.1 Introduction
2.5.2 Immuno-Oncology Assays Types
2.6 Immuno-Oncology Assays Segmentation
2.6.1 Immuno-Oncology Assays Segmentation by Technology
3. GLOBAL MARKET ANALYSIS
3.1 Global Immuno-Oncology Market Analysis
3.1.1 Global Immuno-Oncology Market by Value
3.1.2 Global Immuno-Oncology Market by Region (North America and ROW)
3.2 Global Immuno-Oncology Assays Market Analysis
3.2.1 Global Immuno-Oncology Assays Market by Value
3.2.2 Global Immuno-Oncology Assays Market by Region (North America, Europe, Asia-Pacific and Rest of World)
3.2.3 Global Immuno-Oncology Assays Market by Application (Clinical Diagnostic and Research)
4. REGIONAL MARKET ANALYSIS
4.1 North America Immuno-Oncology Market Analysis
4.1.1 North America Immuno-Oncology Market by Value
4.2 ROW Immuno-Oncology Market Analysis
4.2.1 ROW Immuno-Oncology Market by Value
4.3 North America Immuno-Oncology Assays Market Analysis
4.3.1 North America Immuno-Oncology Assays Market by Value
4.4 Europe Immuno-Oncology Assays Market Analysis
4.4.1 Europe Immuno-Oncology Assays Market by Value
4.5 APAC Immuno-Oncology Assays Market Analysis
4.5.1 APAC Immuno-Oncology Assays Market by Value
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Increase in Oncology Spending
5.1.2 Approval of New Active Substance (NAS) in Oncology
5.1.3 Rising Cancer Cases
5.1.4 Unhealthy Changes in Dietary Patterns
5.1.5 Excessive Use of Tobacco
5.1.6 Rise in Alcohol Consumption
5.2 Challenges
5.2.1 Lower Composite Success Rate of Oncology Clinical Trials
5.2.2 Side-Effects after Immunotherapy
5.2.3 High Cost Involved
5.3 Market Trends
5.3.1 Evolution of Biosimilars in Oncology
5.3.2 Accelerating Immuno-Oncology Research
5.3.3 Purchasing and Reimbursement Actions
6. COMPETITIVE LANDSCAPE
6.1 Global Immuno-Oncology Market: A Financial Comparison
6.2 Global Immuno-Oncology Market Players by Research and Development
7. COMPANY PROFILES
7.1 Merck and Co.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Pfizer Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Amgen
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 F. Hoffmann-La Roche
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
LIST OF FIGURES
Figure 1: Cancer-Targeting Immunotherapy Types
Figure 2: Immuno-Oncology Segmentation by Application
Figure 3: Organs Functions during Immunotherapy
Figure 4: Benefits of Immuno-Oncology
Figure 5: Risks of Immuno-Oncology
Figure 6: Cell-Based Immuno-Oncology Assays
Figure 7: Immuno-Oncology Assays Segmentation by Technology
Figure 8: Global Immuno-Oncology Market by Value; 2018-2023 (US$ Billion)
Figure 9: Global Immuno-Oncology Market by Region; 2018 (Percentage, %)
Figure 10: Global Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 11: Global Immuno-Oncology Assays Market by Region; 2018 (Percentage, %)
Figure 12: Global Immuno-Oncology Assays Market by Application; 2018 (Percentage, %)
Figure 13: North America Immuno-Oncology Market by Value; 2018-2023 (US$ Billion)
Figure 14: ROW Immuno-Oncology Market by Value; 2018-2023 (US$ Billion)
Figure 15: North America Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 16: Europe Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 17: APAC Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 18: Global spending on Oncology; 201-2023 (US$ Billion)
Figure 19: New Active Substance Approvals in Oncology; 2018
Figure 20: Global Cancer Cases; 2015-2035 (Million)
Figure 21: Global Packed Food Sales; 2015-2019 (US$ Trillion)
Figure 22: Global Cigarettes, Smoking Tobacco and Cigars Revenue; 2018-2023 (US$ Billion)
Figure 23: Global Alcohol Consumption by Type & Global Alcohol Consumption by Volume; 2012-2017 (Liters of Alcohol per Person, Billion Liters)
Figure 24: Composite Success Rate of Oncology Clinical Trials; 2010-2018 (Percentage, %)
Figure 25: Global Immuno-Oncology Market Players by Research and Development Expenses; 2017-2018 (US$ Billion)
Figure 26: Merck and Co. Segments Overview
Figure 27: Merck and Co. Sales; 2018-2014 (US$ Billion)
Figure 28: Merck and Co. Sales by Segments; 2018
Figure 29: Merck and Co. Sales by Region; 2018
Figure 30: Pfizer Inc. Revenue; 2018-2014 (US$ Billion)
Figure 31: Pfizer Inc. Revenue by Segments; 2018
Figure 32: Pfizer Inc. Revenue by Region; 2018
Figure 33: Amgen Total Revenue; 2018-2014 (US$ Billion)
Figure 34: Amgen Total Revenue by Products; 2018
Figure 35: Amgen Total Revenue by Region; 2018
Figure 36: F. Hoffmann-La Roche Sales; 2018-2014 (US$ Billion)
Figure 37: F. Hoffmann-La Roche Sales by Segments; 2018
Figure 38: F. Hoffmann-La Roche Sales by Region; 2018
Table 1: Global Immuno-Oncology Market: A Financial Comparison; 2018 (US$ Billion)
Figure 1: Cancer-Targeting Immunotherapy Types
Figure 2: Immuno-Oncology Segmentation by Application
Figure 3: Organs Functions during Immunotherapy
Figure 4: Benefits of Immuno-Oncology
Figure 5: Risks of Immuno-Oncology
Figure 6: Cell-Based Immuno-Oncology Assays
Figure 7: Immuno-Oncology Assays Segmentation by Technology
Figure 8: Global Immuno-Oncology Market by Value; 2018-2023 (US$ Billion)
Figure 9: Global Immuno-Oncology Market by Region; 2018 (Percentage, %)
Figure 10: Global Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 11: Global Immuno-Oncology Assays Market by Region; 2018 (Percentage, %)
Figure 12: Global Immuno-Oncology Assays Market by Application; 2018 (Percentage, %)
Figure 13: North America Immuno-Oncology Market by Value; 2018-2023 (US$ Billion)
Figure 14: ROW Immuno-Oncology Market by Value; 2018-2023 (US$ Billion)
Figure 15: North America Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 16: Europe Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 17: APAC Immuno-Oncology Assays Market by Value; 2018-2023 (US$ Billion)
Figure 18: Global spending on Oncology; 201-2023 (US$ Billion)
Figure 19: New Active Substance Approvals in Oncology; 2018
Figure 20: Global Cancer Cases; 2015-2035 (Million)
Figure 21: Global Packed Food Sales; 2015-2019 (US$ Trillion)
Figure 22: Global Cigarettes, Smoking Tobacco and Cigars Revenue; 2018-2023 (US$ Billion)
Figure 23: Global Alcohol Consumption by Type & Global Alcohol Consumption by Volume; 2012-2017 (Liters of Alcohol per Person, Billion Liters)
Figure 24: Composite Success Rate of Oncology Clinical Trials; 2010-2018 (Percentage, %)
Figure 25: Global Immuno-Oncology Market Players by Research and Development Expenses; 2017-2018 (US$ Billion)
Figure 26: Merck and Co. Segments Overview
Figure 27: Merck and Co. Sales; 2018-2014 (US$ Billion)
Figure 28: Merck and Co. Sales by Segments; 2018
Figure 29: Merck and Co. Sales by Region; 2018
Figure 30: Pfizer Inc. Revenue; 2018-2014 (US$ Billion)
Figure 31: Pfizer Inc. Revenue by Segments; 2018
Figure 32: Pfizer Inc. Revenue by Region; 2018
Figure 33: Amgen Total Revenue; 2018-2014 (US$ Billion)
Figure 34: Amgen Total Revenue by Products; 2018
Figure 35: Amgen Total Revenue by Region; 2018
Figure 36: F. Hoffmann-La Roche Sales; 2018-2014 (US$ Billion)
Figure 37: F. Hoffmann-La Roche Sales by Segments; 2018
Figure 38: F. Hoffmann-La Roche Sales by Region; 2018
Table 1: Global Immuno-Oncology Market: A Financial Comparison; 2018 (US$ Billion)
